gp100 280-9V is a modified melanocyte antigen fragment containing a valine substitution enhancing structural stability. The peptide supports studies of antigen presentation, peptide-MHC interaction, and sequence-dependent folding. Researchers use it to model hydrophobic packing and residue-specific conformational effects. Its defined motif aids immunological and biochemical analyses.
CAT No: ta-029
gp100 280-9V is a synthetic peptide corresponding to a specific epitope within the human glycoprotein 100 (gp100), a melanocyte differentiation antigen widely studied in immunology and cancer research. As a well-characterized peptide fragment, it plays a critical role in the investigation of antigen processing, T-cell recognition, and immune response mechanisms, particularly in the context of melanoma. Its defined sequence and immunogenic properties make it an indispensable tool for researchers examining peptide-MHC interactions and the specificity of cytotoxic T lymphocyte (CTL) responses.
Antigen Presentation Studies: The peptide is frequently employed in studies analyzing the presentation of defined epitopes by major histocompatibility complex (MHC) molecules. Researchers utilize this peptide to load antigen-presenting cells (APCs) in vitro, facilitating controlled investigations of peptide binding affinity, stability, and presentation kinetics. Such experiments contribute to a deeper understanding of how peptide antigens are processed and recognized by the immune system, supporting efforts to elucidate the molecular underpinnings of antigen-specific immune surveillance.
T-Cell Activation Assays: gp100 280-9V serves as a model antigen in functional assays designed to assess T-cell activation, proliferation, and effector function. By pulsing APCs or target cells with the peptide, investigators can monitor CTL responses, cytokine secretion, and cytolytic activity in a highly specific manner. These studies provide valuable insights into T-cell receptor (TCR) specificity, cross-reactivity, and the parameters governing effective immune recognition, furthering the development of immunological tools and reagents.
Epitope Mapping and Immunogenicity Research: The defined sequence of this peptide enables precise mapping of T-cell epitopes within gp100, supporting research into immunodominance and peptide immunogenicity. Through systematic screening of T-cell responses to this and related peptides, scientists can delineate critical determinants of antigenicity, optimize peptide selection for immunological assays, and refine the design of experimental models for studying antigen-specific immunity.
Peptide-MHC Binding Analysis: The peptide is widely used in quantitative and qualitative studies of peptide-MHC class I interactions. By incorporating it into binding assays, researchers can evaluate the affinity and stability of peptide-MHC complexes, facilitating the characterization of MHC restriction elements and the impact of sequence modifications on binding efficiency. These data are essential for advancing the rational design of peptide-based probes and for understanding the structural basis of antigen presentation.
Synthetic Peptide Controls: As a standardized, well-defined peptide, gp100 280-9V functions as an essential positive control in a variety of immunological and biochemical assays. Its use ensures reproducibility and reliability in experiments involving peptide loading, T-cell stimulation, and MHC tetramer generation. By providing a consistent reference point, it enables meaningful comparisons across different assay platforms and experimental conditions, supporting robust data interpretation and methodological validation.
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More